Jacobson Pharma Corporation Limited, through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally. It operates in two segments, Generic Drugs and Branded Healthcare. The company offers generic drugs for various therapeutic categories, including cardiovascular, central nervous, gastrointestinal, respiratory, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatological, and anti-allergic. It also provides branded medicines; health and wellness products; proprietary Chinese medicines; treasury services; and management services. In addition, the company is involved in the manufacture, sale, trading of pharmaceutical products; property holding activities; holding of pharmaceutical licenses; trading of medical supplies; sales of healthcare and herbal products; and procurement of packaging materials. It serves public and private sector institutions and registered pharmacies, as well as private doctors. Jacobson Pharma Corporation Limited was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong.